EMEA Oral Vaccines Market 2017 Share, Trend, Segmentation and Forecast 2017
EMEA (Europe, Middle East and Africa) Oral Vaccines Market Report 2017
SUMMARY
In this report, the EMEA Oral Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Oral Vaccines for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1192508-emea-europe-middle-east-and-africa-oral-vaccines-market-report-2017
EMEA Oral Vaccines market competition by top manufacturers/players, with Oral Vaccines sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
GlaxoSmithKline Plc.
PaxVax Corporation
Merial, Inc.
Merck Sharp & Dohme Corp
VALNEVA Canada Inc.
QUíMICA SUIZA S.A
Immunitor, Inc
Aventis (Sanofi S.A.)
Serum Institute of India Pvt. Ltd
Swiss Serum and Vaccine Institute Berne
Bull Bio - NCIPD Ltd.
Vaxart, Inc.
Shantha Biotechnics
Crucell (Janssen Global Services, LLC)
On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
Live Attenuated Vaccines
Killed/Inactivated Vaccines
Recombinant Vaccines
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Oral Vaccines for each application, including
Polio
Rabies
Rotavirus
Cholera
HIV
Respiratory Infections
Influenza
Tuberculosis
Others
ACCESS REPORT @ https://www.wiseguyreports.com/reports/1192508-emea-europe-middle-east-and-africa-oral-vaccines-market-report-2017
EMEA (Europe, Middle East and Africa) Oral Vaccines Market Report 2017
1 Oral Vaccines Overview
1.1 Product Overview and Scope of Oral Vaccines
1.2 Classification of Oral Vaccines
1.2.1 EMEA Oral Vaccines Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Oral Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Live Attenuated Vaccines
1.2.4 Killed/Inactivated Vaccines
1.2.5 Recombinant Vaccines
1.2.6 Others
1.3 EMEA Oral Vaccines Market by Application/End Users
1.3.1 EMEA Oral Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Polio
1.3.3 Rabies
1.3.4 Rotavirus
1.3.5 Cholera
1.3.6 HIV
1.3.7 Respiratory Infections
1.3.8 Influenza
1.3.9 Tuberculosis
1.3.10 Others
1.4 EMEA Oral Vaccines Market by Region
1.4.1 EMEA Oral Vaccines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Oral Vaccines (2012-2022)
1.5.1 EMEA Oral Vaccines Sales and Growth Rate (2012-2022)
1.5.2 EMEA Oral Vaccines Revenue and Growth Rate (2012-2022)
2 EMEA Oral Vaccines Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Oral Vaccines Market Competition by Players/Manufacturers
2.1.1 EMEA Oral Vaccines Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Oral Vaccines Revenue and Share by Players (2012-2017)
2.1.3 EMEA Oral Vaccines Sale Price by Players (2012-2017)
2.2 EMEA Oral Vaccines (Volume and Value) by Type/Product Category
2.2.1 EMEA Oral Vaccines Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Oral Vaccines Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Oral Vaccines Sale Price by Type (2012-2017)
2.3 EMEA Oral Vaccines (Volume) by Application
2.4 EMEA Oral Vaccines (Volume and Value) by Region
2.4.1 EMEA Oral Vaccines Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Oral Vaccines Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Oral Vaccines Sales Price by Region (2012-2017)
3 Europe Oral Vaccines (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Oral Vaccines Sales and Value (2012-2017)
3.1.1 Europe Oral Vaccines Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Oral Vaccines Revenue and Growth Rate (2012-2017)
3.2 Europe Oral Vaccines Sales and Market Share by Type
…CONTINUED
FOR ANY QUERY, CONTACT US @ https://www.wiseguyreports.com/enquiry/1192508-emea-europe-middle-east-and-africa-oral-vaccines-market-report-2017
Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
